Duality Biotherapeutics (09606.HK) ：Passes Shanghai CSRC Bureau IPO Tutoring Inspection for STAR Market Listing

NewTimeSpace · 2026/06/10 08:02 · By Xuran Lin

Newtimespace (newtimespace.com) reports that Duality Biotherapeutics (9606.HK) announced it is currently undergoing tutoring by CITIC Securities for the proposed issuance of RMB-denominated ordinary shares to be listed on the Shanghai Stock Exchange STAR Market, and has passed the tutoring inspection by the Shanghai Bureau of the China Securities Regulatory Commission, with the Company committing to announce further progress in accordance with relevant laws and regulations.

Newtimespace (newtimespace.com) reports that Duality Biotherapeutics, Inc. (9606.HK) announced that, in relation to the proposed issuance of ordinary shares to be listed on the Shanghai Stock Exchange STAR Market and traded in RMB as referenced in its previous announcements dated October 17, 2025, and April 13, 2026, and the circular dated April 14, 2026, the Company is currently undergoing tutoring by CITIC Securities Co., Ltd. and has passed the tutoring inspection conducted by the Shanghai Bureau of the China Securities Regulatory Commission. The Company will announce the progress of the proposed listing in a timely manner in accordance with relevant laws and regulations.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.

Tags：

Duality Biotherapeutics 09606.HK STAR Market